Liver disorders in pregnancy range from mild reversible changes to sev
ere fulminant fatal disease. Intrahepatic cholestasis is common in Sca
ndinavia and Chile and the pathogenesis remains unknown. The use of in
travenous S-adenosyl-L-methionine for symptomatic and biochemical impr
ovement has been encouraging. In severe liver disease associated with
pregnancy, liver transplantation has been performed and has been succe
ssful. Conception after liver transplantation has also been documented
, unassociated with any teratogenicity or intrauterine growth failure.
A high incidence of preeclampsia has been noted, however. It is advoc
ated that patients wait 9 to 12 months after transplantation before tr
ying to conceive. The recommended contraception is a barrier method, n
ot an intrauterine device because of risk of infection, nor oral contr
aceptives, which may cause difficulty with cyclosporine dosing. Ischem
ic hepatitis is a common disorder, frequently self-limiting, depending
on the underlying pathogenesis. Rapid elevation of the aminotransfera
ses and lactic dehydrogenase is associated with an equally rapid resol
ution in this disorder. Renal impairment, carbohydrate intolerance, an
d mental confusion appear to be additional factors in the clinical man
ifestation. Ascites can be associated with a severe pleural effusion o
ften resistant to standard management. The use of the transjugular int
rahepatic portosystemic stent-shunt procedure has been documented to b
e effective in the management of this entity.